Literature DB >> 26854682

Author`s Reply.

Tahereh Saedi1, Mohammad Ali Sadrameli2, Sedigheh Saedi2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26854682      PMCID: PMC5336718     

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, We thank the authors of the letter for their valuable comments. In our study entitled “Coronary slow flow: Benign or ominous?” published in Anatolian Journal of Cardiology 2015; 15: 531-5 (1), the focus was on the evaluation of characteristics of patients presenting with coronary ischemic symptoms and who happened to only have coronary slow flow phenomenon in coronary angiography; the goal was to understand the natural history of these patients. For this reason, the patients who were admitted for catheterization due to causes other than coronary symptoms were excluded. Congenital patients have their own specific underlying cardiac pathophysiology, with abnormal coronary anatomies; therefore, they were not taken into account in our study. None of the evaluated patients suffered from specific arrhythmias. Prescribed drugs might have varied based on individual patient’s conditions, but the core components remained constant in the majority of cases. Regarding echocardiography, echogenicity did not really impose a problem that necessitated the use of contrast material or other modalities, and global left ventricular function was determined in different echocardiographic planes. Last but not least, we agree with the comment that evaluation for further characteristics, including those parameters mentioned by the authors of the letter, could be related and important in patients with coronary slow flow phenomenon and should become the subject of future studies.
  1 in total

1.  Coronary slow flow: Benign or ominous?

Authors:  Mohammad Ali Sadr-Ameli; Sedigheh Saedi; Tahereh Saedi; Mohsen Madani; Mehrdad Esmaeili; Behshid Ghardoost
Journal:  Anatol J Cardiol       Date:  2014-07-11       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.